Earnings Call

As Forgent Power Solutions preps its 2026 results, its performance offers a crucial look into the health of data centers and grid modernization.

Haivision's upcoming Q3 results face intense scrutiny after a challenging second quarter. Investors seek signs of recovery amid market shifts and strategic pivots.

As Mesoblast prepares its year-end webcast, investors weigh a stellar $115M Ryoncil launch against cash burn and the high-stakes progress of its next-gen therapies.

As AOUT prepares its Q1 FY27 report, investors look past the numbers to see if its diverse brand strategy can navigate market headwinds and deliver on growth.

As Movado Group readies its Q2 earnings, investors watch if its brand strategy and digital focus can sustain strong performance against industry headwinds.

As Evaxion prepares its Q2 update, investors watch to see if its AI-Immunology™ platform can deliver the financial and clinical results for long-term value.

As HSDT prepares to report Q2 results, investors are watching closely. Is its unique strategy of tying shareholder value directly to the Solana ecosystem paying off?

As BioPorto preps its H1 2026 results, its promising NGAL kidney test faces a crucial moment. Can it sustain growth and appease a global market?

With a NYSE delisting notice and a dividend under scrutiny, Lument Finance Trust's Q2 report is more than just numbers—it's a test of its strategy.

As VolitionRx readies its Q2 update, investors and scientists look for proof that its pioneering epigenetic tests can translate into commercial success.

As Semtech prepares its Q2 earnings call, all eyes are on its performance in AI data centers and IoT. Will the results validate the market's bullish outlook?

As KNOT Offshore Partners prepares its Q2 earnings report, the market watches closely. Brazil's oil surge provides a powerful tailwind amid a buyout offer.

As JLL Income Property Trust prepares its Q2 earnings call, investors are watching. Its diversified portfolio may offer a unique glimpse into real estate's future.

As SKYX Platforms preps its Q2 earnings call, investors look beyond the numbers to its patent moat, e-commerce engine, and leadership's execution strategy.

As Intchains prepares its H1 2026 report, it's not just financials on the line. It's a test of a bold strategy to build a Web3 ecosystem beyond Bitcoin.

As Birchtech preps for its Q2 earnings, the market is watching. Its PFAS-fighting tech is promising, but can it fix a battered stock and prove its path to profit?

As Biofrontera preps its Q2 report, investors weigh record revenue and expanded margins against persistent losses and a critical need for cash flow breakeven.

As Cisco prepares its Q4 results, all eyes are on its multi-billion dollar AI strategy. Will the numbers validate its pivot to an AI-first future?

As John Deere preps for its Q3 earnings, all eyes are on whether its tech pivot and construction strength can offset a soft farm economy. We break it down.

As Stella-Jones reports Q2 earnings, investors watch if robust demand for utility and rail products can offset residential market volatility and cost pressures.